U.S. Securities and Exchange Commission
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 27, 2002
-------------
HUAYANG INTERNATIONAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Nevada 000-30173 58-1667944
(State or other) (Commission (I.R.S. Employer
jurisdiction File Number) Identification Number)
of incorporation
386 Qing Nian Avenue, Shenyang, China 110003
(Address of principal executive offices) (Zip code)
011 (86)(24) 2318-0688
(Issuer's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Events and Regulation FD Disclosure
On June 27, 2002, Huayang International Holdings, Inc. (the "Company")
issued a press release announcing the execution of a letter of intent to
acquire a controlling interest in Jiahe Medicine Group. A copy of the press
release dated June 27, 2002 is attached as exhibit 99.1 hereto and
incorporated herein by reference.
Item 7. Exhibits
99.1 Press Release dated June 27, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized.
Huayang International Holdings, Inc.
Date: June 27, 2002 /s/ Gao WanJun
-----------------
Name: Gao WanJun
Title: President and Chief
Executive Officer
EXHIBIT INDEX
Exhibit
Number Description
- ------- -----------
99.1 Press release, dated June 27, 2002, of Huayang International
Holdings, Inc.